A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Maverick Capital LTD holds 39,596 shares of COLL stock, worth $1.37 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
39,596
Previous 8,873 346.25%
Holding current value
$1.37 Million
Previous $344,000 270.35%
% of portfolio
0.03%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$31.36 - $39.99 $963,473 - $1.23 Million
30,723 Added 346.25%
39,596 $1.27 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $40.91 $277,103 - $362,994
8,873 New
8,873 $344,000
Q2 2023

Aug 14, 2023

SELL
$21.06 - $24.0 $18,848 - $21,480
-895 Reduced 7.92%
10,401 $223,000
Q1 2023

May 15, 2023

BUY
$23.0 - $29.88 $12,765 - $16,583
555 Added 5.17%
11,296 $270,000
Q4 2022

Feb 14, 2023

SELL
$16.14 - $23.55 $64,414 - $93,988
-3,991 Reduced 27.09%
10,741 $249,000
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $227,756 - $296,113
14,732 New
14,732 $236,000
Q3 2021

Nov 15, 2021

SELL
$17.75 - $25.39 $599,080 - $856,937
-33,751 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$21.74 - $25.28 $733,746 - $853,225
33,751 New
33,751 $798,000
Q1 2021

May 17, 2021

SELL
$19.25 - $26.1 $133,325 - $180,768
-6,926 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$17.83 - $22.29 $123,490 - $154,380
6,926 New
6,926 $139,000
Q2 2019

Aug 14, 2019

SELL
$10.62 - $16.59 $4.2 Million - $6.55 Million
-395,080 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$13.58 - $18.72 $5.37 Million - $7.4 Million
395,080 New
395,080 $5.98 Million
Q4 2018

Feb 14, 2019

SELL
$14.78 - $19.68 $6.24 Million - $8.3 Million
-421,993 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$14.16 - $24.3 $36,773 - $63,107
-2,597 Reduced 0.61%
421,993 $6.22 Million
Q2 2018

Aug 14, 2018

BUY
$21.79 - $28.29 $9.25 Million - $12 Million
424,590 New
424,590 $10.1 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.18B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.